Regulation of TNFα and interleukin-10 production by prostaglandins I2 and E2:: studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists

被引:138
|
作者
Shinomiya, S
Naraba, H
Ueno, A
Utsunomiya, I
Maruyama, T
Ohuchida, S
Ushikubi, F
Yuki, K
Narumiya, S
Sugimoto, Y
Ichikawa, A
Oh-ishi, S
机构
[1] Kitasato Inst, Minato Ku, Tokyo 1088642, Japan
[2] Kitasato Univ, Sch Pharmaceut Sci, Dept Pharmacol, Minato Ku, Tokyo 1088641, Japan
[3] Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka 6188585, Japan
[4] Asahikawa Med Coll, Dept Pharmacol, Asahikawa, Hokkaido 0788510, Japan
[5] Kyoto Univ, Fac Pharmaceut Sci, Dept Physiol Chem, Kyoto 6068501, Japan
[6] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan
[7] Kitasato Inst, Minato Ku, Tokyo 1088642, Japan
关键词
LP receptor; EP2; receptor; EP4; TNF alpha; IL-10; zymosan;
D O I
10.1016/S0006-2952(01)00586-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To know which receptors of prostaglandins are involved in the regulation of TNF alpha and interleukin 10 (IL-10) production, we examined the production of these cytokines in murine peritoneal macrophages stimulated with zymosan. The presence of PGE, or the PGI, analog carbacyclin in the medium reduced the TNF alpha production to one-half, whereas IL-10 production increased several fold; and indomethacin caused the reverse effects, suggesting that endogenous prostaglandins may have a regulatory effect on the cytokine production. Among prostaglandin E (EP) receptor-selective synthetic agonists, EP2 and EP4 agonists caused down-regulation of the zymosan-induced TNF alpha production, but up-regulation on the IL-IO production; while EP1 and EP3 agonists showed no effect. Macrophages harvested from prostaglandin I (IP) receptor-deficient mice showed the up- and down-regulatory effects on the cytokine production by the EP2 and EP4 agonists or PGE(2), but no effect was obtained by carbacyclin. On the contrary, macrophages from EP2-deficient mice showed the effect by PGE(2), carbacyclin, and the EP4 agonist, but not by the EP2 agonist; and the cells from EP4-deficient mice showed the effect by PGE,, carbacyclin, and EP2 agonist, but not by the EP3 agonist. These functional effects of prostaglandins well accorded with the mRNA expression of TNF alpha and IL-10 when such expression was examined by the RT-PCR method. The peritoneal macrophages from normal mice expressed IF, EP2, and EP4 receptors, but not EPI and EP3, when examined by RT-PCR. Thus the results suggest that PGI, and PGE, generated simultaneously with cytokines by macrophages treated with zymosan may influence the cytokine production through IF, EP2, and EP4 receptors. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1153 / 1160
页数:8
相关论文
共 50 条
  • [41] Systemic prostaglandin E2 administration induces bone loss in mice by a mechanism that requires the EP4 but not the EP2 receptor subtype.
    Perry, PY
    Crawford, DT
    Oi, H
    Ke, H
    Pan, LC
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S224 - S224
  • [42] Suppression of tumour necrosis factor-α production in human blood by interactions between prostaglandin E2, interleukin-10 and transforming growth factor-β
    Habeeb, F
    Rotondo, D
    Davidson, J
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137
  • [43] The effect of the anti-inflammatory cytokines interleukin-4 and interleukin-10 on lipopolysaccharide-stimulated production of prostaglandin E2 by cultured human decidual cells
    Simhan, HN
    Chura, JC
    Rauk, PN
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2004, 64 (1-2) : 1 - 7
  • [44] ADP-RIBOSYLATION OF GI-ALPHA BY INSULIN AND THE REGULATION OF PROSTAGLANDIN-E1/I2 (PGE1/I2) RECEPTOR NUMBER ON PLATELET SURFACE
    KAHN, N
    ARORA, R
    SINHA, AK
    CLINICAL RESEARCH, 1993, 41 (02): : A163 - A163
  • [45] Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice
    Mizutani, H.
    Ishihara, Y.
    Izawa, A.
    Fujihara, Y.
    Kobayashi, S.
    Gotou, H.
    Okabe, E.
    Takeda, H.
    Ozawa, Y.
    Kamiya, Y.
    Kamei, H.
    Kikuchi, T.
    Yamamoto, G.
    Mitani, A.
    Nishihara, T.
    Noguchi, T.
    JOURNAL OF PERIODONTAL RESEARCH, 2013, 48 (06) : 748 - 756
  • [46] Prostaglandin E2 enhances interleukin-8 production via EP4 receptor in human pulmonary microvascular endothelial cells
    Aso, Hiromichi
    Ito, Satoru
    Mori, Akemi
    Morioka, Masataka
    Suganuma, Nobukazu
    Kondo, Masashi
    Imaizumi, Kazuyoshi
    Hasegawa, Yoshinori
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2012, 302 (02) : L266 - L273
  • [47] Prostaglandin E2 receptor subtype EP4 mediated inhibition of osteoclasts' development and MMP-9 production in rheumatoid synovitis.
    Nozaki, T
    Yamada, H
    Akaogi, J
    Kikukawa, T
    Mori, T
    Takahashi, K
    Ozaki, S
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S351 - S351
  • [48] Prostaglandin E2 activates EP4 receptor subtype to increase cyclic AMP production in rat dorsal root ganglion cells, in vitro
    Wise, H.
    NEUROSIGNALS, 2006, 15 (03) : 118 - 118
  • [49] Correction: Corrigendum: Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
    Krisztián Németh
    Asada Leelahavanichkul
    Peter S T Yuen
    Balázs Mayer
    Alissa Parmelee
    Kent Doi
    Pamela G Robey
    Kantima Leelahavanichkul
    Beverly H Koller
    Jared M Brown
    Xuzhen Hu
    Ivett Jelinek
    Robert A Star
    Éva Mezey
    Nature Medicine, 2009, 15 : 462 - 462
  • [50] The effect of the anti-inflammatory cytokines interleukin-10 and interleukin-13 on lipopolysaccharide-stimulated production of prostaglandin E2 by cultured human decidual cells.
    Chura, JC
    Simhan, HN
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 72A - 72A